March 14, 2010 — Late-breaking data presented at the American College of Cardiology's 59th annual scientific session from the landmark EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) trial suggests that an investigational minimally invasive mitral repair device may be an effective treatment option for patients with significant mitral regurgitation (MR).
